Support AlterNet
Do you value the information you're getting from AlterNet? Please show your support with a tax-deductible donation.
Feedback
Tell us how we're doing.
Smoking Pot Won't Make You Crazy, But Dealing with the Lies about It Will
Corporate Accountability and WorkPlace:
How to Reframe the Poverty Debate
Margy Waller
Democracy and Elections:
More Unfinished 2008 Election Business: Verifiable Vote Counts
Steven Rosenfeld
DrugReporter:
A New Approach to Drugs Would Save New York Hundreds of Millions of Dollars
Gabriel Sayegh
Election 2008:
Franken Lawyer: "We Are Going To Win"
Sam Stein
Environment:
Soil Not Oil: Why We Need to Kick Petroleum Out of Our Farms
Vandana Shiva
ForeignPolicy:
Are Key Obama Advisors in Tune with Neocon Hawks Who Want War with Iran?
Robert Dreyfuss
Health and Wellness:
Renowned Psychiatrists on Drug Company Payrolls
Bruce E. Levine
Hurricane Katrina:
From the Bayou to Baghdad: Mission Not Accomplished
Amy Goodman
Immigration:
Immigration Reform After Bush: Let's Put an End to Punitive Policies
Roberto Lovato
Media and Technology:
Born Digital: Understanding the First Generation of Digital Natives
Doron Taussig
Movie Mix:
Love Bites: What Sexy Vampires Tell Us About Our Culture
Sarah Seltzer
Reproductive Justice and Gender:
SNL's Amy Poehler: Smart Girls Have More Fun
Marianne Schnall
Rights and Liberties:
Mormon Homophobia: Up Close and Personal
Sheldon Rampton
Sex and Relationships:
9 Ways to Halt the Right Wing Culture Wars and Bring Sanity to Sexual Policy
David Rosen
War on Iraq:
Would You "Shoot an Iraqi" in Cyberspace?
Gabriel Thompson
Water:
Is the Latest Eco-Term Just Corporate Hype?
Jeff Conant
Smoking pot won't make you crazy, but trying to find the truth behind the recent rash of headlines regarding a supposed link between cannabis and mental illness might.
According to the Associated Press and other news sources, a new study in the British medical journal The Lancet reports that smoking cannabis -- even occasionally -- can increase one's risk of becoming psychotic. It sounds alarming at first, but a closer look at the evidence reveals that there's less here than the headlines imply.
First, there is no new study. The paper published in The Lancet is a meta-analysis -- a summary of seven studies that previously appeared in other journals, including some that were published decades ago. Second, the touted association between cannabis and mental illness is small -- about the same size as the link between head injury and psychosis. Finally, despite what some new sources suggest, this association is hardly proof of a cause-and-effect relationship between cannabis and psychosis,
So why the sudden fuss?
Part of the answer is political. New British Prime Minister Gordon Brown longs to stiffen penalties against marijuana users. One way to justify this move involves convincing the public that The Lancet proved that puffing the weed will make you batty. Of course, that's not what the article says at all.
In fact, investigators actually reported that cannabis use was associated with a slight increase in psychotic outcomes. However, the authors emphasized (even if many in the media did not) that this small association does not reflect a causal relationship. Folks with psychoses use all intoxicants more often than other people do, including alcohol and tobacco.
Cannabis use can correlate with mental illness for many reasons. People often turn to cannabis to alleviate the symptoms of distress. A recent study performed in Germany showed that cannabis offsets certain cognitive declines in schizophrenic patients. Another study shows that psychotic symptoms predict later use of cannabis, suggesting that people might turn to the plant for help rather than become ill after use.
Perhaps the most impressive evidence against the cause-and-effect relationship concerns the unvarying rate of psychoses across different eras and different countries. People are no more likely to be psychotic in Canada or the United States (two nations where large percentages of citizens use cannabis) than they are in Sweden or Japan (where self-reported marijuana use is extremely low). Even after the enormous popularity of cannabis in the 1960s and 1970s, rates of psychotic disorders haven't increased.
Despite this evidence, we'd like to spread the word that cannabis is not for everybody. Teens should avoid the plant. Folks with a predisposition for mental illness should stay away, too. This potential for health risks in a few people, however, does not justify criminal prohibitions for everyone. (We wouldn't pass blanket prohibitions against alcohol simply to protect pregnant women, for example.) The underground market does an extremely poor job of keeping marijuana out of the hands of teens and others who should stay away from it. A regulated market could better educate users to potential risks and prohibit sales to young people.
Consequently, the review in The Lancet suggests that if cannabis really does alter risk for mental illness, we can't leave control of sales to folks who are willing to break the law. Instead, a taxed, regulated, age-restricted market is our best chance to keep any negative consequences of marijuana under control.
See more stories tagged with: lancet, propaganda, uk, pot, psychosis
Paul Armentano is the senior policy analyst for NORML and the NORML Foundation in Washington, DC. He resides in Pleasant Hill, California. Mitch Earleywine is Associate Professor of Psychology at The University at Albany, State University of New York and author of "Understanding Marijuana" (Oxford University Press).
Liked this story? Get top stories in your inbox each week from AlterNet! Sign up now »